GlassScriptPhysician profile
Gloria L Wong
NPI 1588760854
$1,710.61
in general payments reported to CMS, 2019-2025
16 companies · $622 in 2025
The $622 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $247 · 2022: $556 · 2023: $188 · 2024: $97.47 · 2025: $622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $907.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $197.06 | 2025 | Sapien 3 Ultra Resilia |
| Neurocrine Biosciences, INC. | $173.88 | 2022 | |
| Madrigal Pharmaceuticals | $145.18 | 2025 | Rezdiffra |
| Alnylam Pharmaceuticals INC. | $143.71 | 2025 | Onpattro |
| Boston Scientific Corporation | $125.00 | 2021 | |
| Abbvie INC. | $123.79 | 2023 | |
| Melinta Therapeutics, LLC | $121.95 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $121.83 | 2021 | |
| Novo Nordisk INC | $98.21 | 2022 | |
| Medtronic, INC. | $97.47 | 2024 | Intellis Adaptivestim |
| Sanofi-Aventis U.S. LLC | $81.98 | 2022 | |
| Scynexis, INC. | $80.27 | 2022 | |
| Abbott Laboratories | $70.96 | 2025 | Infinity |
| Teleflex LLC | $65.57 | 2025 | Barrigel |
| Astrazeneca Pharmaceuticals LP | $50.10 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $13.65 | 2023 | Speedicath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gloria Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.